Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diamandis

Showing results (611-620 of 924) with videos related to

Pageof 93
Sort By:
The Prostate|January 9, 2003
Serum human glandular kallikrein (hK2) and insulin-like growth factor 1 (IGF-1) improve the discrimination between prostate cancer and benign prostatic hyperplasia in combination with total and %free PSAAndreas Scorilas, Mario Plebani, Saverio Mazza, et al.
Clinical Biochemistry|January 7, 2020
Kallikrein-related peptidases protein expression in lymphoid tissues suggests potential implications in immune responsePanagiota S Filippou, Annie H Ren, Antoninus Soosaipillai, et al.
Biochimica Et Biophysica Acta|May 10, 2005
A survey of alternative transcripts of human tissue kallikrein genesLisa Kurlender, Carla Borgono, Iacovos P Michael, et al.
Blood|November 26, 2008
Increased expression of urokinase plasminogen activator in Quebec platelet disorder is linked to megakaryocyte differentiationD Kika Veljkovic, Georges E Rivard, Maria Diamandis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancerCarla A Borgoño, Tadaaki Kishi, Andreas Scorilas, et al.
Breast Cancer Research and Treatment|August 15, 2000
Breast cancer prognostic significance of a single nucleotide polymorphism in the proximal androgen response element of the prostate specific antigen gene promoterB Bharaj, A Scorilas, E P Diamandis, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 14, 2004
Molecular cloning of a new gene which is differentially expressed in breast and prostate cancersGeorge M Yousef, Carla A Borgoño, Iacovos P Michael, et al.
Clinical Biochemistry|July 27, 2017
Generation of monoclonal antibodies and development of an immunofluorometric assay for the detection of CUZD1 in tissues and biological fluidsSofia Farkona, Antoninus Soosaipillai, Panagiota Filippou, et al.
Cancer Science|October 30, 2008
Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA)Panteleimon Kountourakis, Amanda Psyrri, Andreas Scorilas, et al.
Thrombosis and Haemostasis|June 15, 2013
Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignanciesJ Dorn, J Bayani, G M Yousef, et al.
Pageof 93

Showing results (611-620 of 924) with videos related to

Sort By:
Pageof 93
The Prostate|January 9, 2003
Serum human glandular kallikrein (hK2) and insulin-like growth factor 1 (IGF-1) improve the discrimination between prostate cancer and benign prostatic hyperplasia in combination with total and %free PSAAndreas Scorilas, Mario Plebani, Saverio Mazza, et al.
Clinical Biochemistry|January 7, 2020
Kallikrein-related peptidases protein expression in lymphoid tissues suggests potential implications in immune responsePanagiota S Filippou, Annie H Ren, Antoninus Soosaipillai, et al.
Biochimica Et Biophysica Acta|May 10, 2005
A survey of alternative transcripts of human tissue kallikrein genesLisa Kurlender, Carla Borgono, Iacovos P Michael, et al.
Blood|November 26, 2008
Increased expression of urokinase plasminogen activator in Quebec platelet disorder is linked to megakaryocyte differentiationD Kika Veljkovic, Georges E Rivard, Maria Diamandis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancerCarla A Borgoño, Tadaaki Kishi, Andreas Scorilas, et al.
Breast Cancer Research and Treatment|August 15, 2000
Breast cancer prognostic significance of a single nucleotide polymorphism in the proximal androgen response element of the prostate specific antigen gene promoterB Bharaj, A Scorilas, E P Diamandis, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 14, 2004
Molecular cloning of a new gene which is differentially expressed in breast and prostate cancersGeorge M Yousef, Carla A Borgoño, Iacovos P Michael, et al.
Clinical Biochemistry|July 27, 2017
Generation of monoclonal antibodies and development of an immunofluorometric assay for the detection of CUZD1 in tissues and biological fluidsSofia Farkona, Antoninus Soosaipillai, Panagiota Filippou, et al.
Cancer Science|October 30, 2008
Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA)Panteleimon Kountourakis, Amanda Psyrri, Andreas Scorilas, et al.
Thrombosis and Haemostasis|June 15, 2013
Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignanciesJ Dorn, J Bayani, G M Yousef, et al.
Pageof 93